Popular Magazines Don't Inform Men About Prostate and Colon Cancer ScreeningSeptember 08, 2004Decisions about screening for prostate and colon cancer require patients to have accurate, balanced information. Unfortunately, men are not getting this information from popular men's magazines. When articles are available, they often do not provide the information necessary for the reader to make an informed decision about screening. A recent study in the Journal of General Internal Medicine reviewed general messaging on prostate and colon cancer screening in popular magazines. In this study, the authors reviewed the top three magazines in six categories (African-American, Men's, Women's, News, General, and Health) with the highest circulation. According to the study, relatively few popular magazine articles provided in-depth information about prostate and colon cancer screening. The study discovered that in-depth articles about these cancers do not appear as frequently as articles about breast cancer. In addition, key points missing from many of the magazine articles were: the relative importance of the various cancer risk factors, risk factors that should lead to earlier screening, and the potential harms, complications, and uncertainties associated with a screening test.
This lack of information may help to explain the public's misperception about the risk of the different types of cancer, as well as the low awareness of the importance of screening for colon cancer and the lack of appreciation of the pros and cons associated with prostate cancer screening. Blackwell Publishing Ltd | |||||||||||||||||||||
|
Related Colon Cancer Current Events and Colon Cancer News Articles Breakthrough optical technology to assess colon cancer risk, accuracy Researchers at NorthShore University HealthSystem (NorthShore) and Northwestern University have discovered that fiber optic technology can for the very first time effectively measure blood levels in the colonic lining (mucosa) in humans, thus having potential applications for analyzing risk of colon cancer. Surgical treatment provides new option for some colorectal cancer patients Research out of Wake Forest University School of Medicine suggests that a surgical technique not traditionally used in advanced abdominal cancer may be a viable treatment option for some patients previously thought to be untreatable, offering the real possibility of extending survival for those patients. Black Americans Are At Greater Risk for Colon Polyps Black Americans have a higher occurrence of colon polyps, according to a new study. This is a significant finding considering the incidence of colon cancer among black men has increased and remained unchanged among black women during the last 20 years. Cancer-causing gut bacteria exposed Normal gut bacteria are thought to be involved in colon cancer but the exact mechanisms have remained unknown. Now, scientists from the USA have discovered that a molecule produced by a common gut bacterium activates signalling pathways that are associated with cancer cells. Brown-Assisted Trial Finds New Colorectal Screening Procedure Is Accurate and Less Invasive More patients stand to benefit from a comprehensive, less invasive method to accurately detect colorectal cancer and precancerous polyps, a multicenter study involving Brown University and institutions nationwide has found. Researchers identify cancer-causing gene in many colon cancers Demonstrating that despite the large number of cancer-causing genes already identified, many more remain to be found, scientists at Dana-Farber Cancer Institute have linked a previously unsuspected gene, CDK8, to colon cancer. '1-hit' event provides new opportunity for colon cancer prevention, say Fox Chase researchers More than 30 years ago, Alfred Knudson Jr., M.D., Ph.D., revolutionized the field of cancer genetics by showing that a person must lose both their paternal and maternal copies of a particular class of cancer-inhibiting genes, called tumor-suppressor genes, in order to develop cancer. Early stage colon cancer characterized by inactivation of gatekeeper gene The absence or inactivation of the RUNX3 gatekeeper gene paves the way for the growth and development of colon cancer, Singapore scientists report in the Sept. issue of the journal Cancer Cell. Previous studies have shown that RUNX3 plays a role in gastric, breast, lung and bladder cancers. Variation of normal protein could be key to resistance to common cancer drug Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug. Anti-Cancer Flower Power Could a substance from the jasmine flower hold the key to an effective new therapy to treat cancer? More Colon Cancer Current Events and Colon Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||